1

2

3

4

5
Himmelsbach Frank, Langkopf Elke, Eckhardt Matthias, Mark Michael, Maier Roland, Lotz Ralf Richard Hermann, Tadayyon Mohammad: (De) 8-[3-amino-piperidin-1-yl]-xanthine, deren herstellung und deren verwendung als arzneimittel, (En) 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments. Boehringer Ingelheim Pharma & Co Kg, Himmelsbach Frank, Langkopf Elke, Eckhardt Matthias, Mark Michael, Maier Roland, Lotz Ralf Richard Hermann, Tadayyon Mohammad, March 4, 2004: WO/2004/018468 (80 worldwide citation)

(EN) The invention relates to substituted xanthines of general formula (I) wherein R1 to R3 have the designations cited in patent claims 1 to 16, and to the tautomers, stereoisomers, mixtures, prodrugs and salts thereof, which have precious pharmacological properties, especially an inhibiting effect ...


6

7
Bailey Murray D, Llinas Brunet Montse: Hepatitis c inhibitor peptide analogs. Boehringer Ingelheim International, Boehringer Ingelheim Pharma & Co Kg, Bailey Murray D, Llinas Brunet Montse, BERNIER Louise G, November 25, 2004: WO/2004/101602 (71 worldwide citation)

Compounds of formula (I) : wherein B, Y, R3, R24, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease.


8
Eckhardt Matthias, Mark Michael, Himmelsbach Frank, Langkopf Elke, Lotz Ralf, Maier Roland: (De) Phenacylxanthinderivate als dpp-iv-hemmer, (En) Phenacyl xanthine derivatives as dpp-iv inhibitor. Boehringer Ingelheim Pharma & Co Kg, Eckhardt Matthias, Mark Michael, Himmelsbach Frank, Langkopf Elke, Lotz Ralf, Maier Roland, March 4, 2004: WO/2004/018467 (69 worldwide citation)

(EN) The invention concerns substituted xanthines of general formula (I), wherein: R1 to R4 are such as defined in Claim 1, and tautomers, stereoisomers, mixtures, prodrugs and salts thereof. Said compounds have advantageous pharmacological properties, in particular an inhibiting effect on the activ ...


9

10
Beaulieu Pierre Louis, Brochu Christian, Chabot Catherine, Jolicoeur Eric, Kawai Stephen, Poupart Marc André, Tsantrizos Youla S: Viral polymerase inhibitors. Boehringer Ingelheim International, Boehringer Ingelheim Pharma & Co Kg, Beaulieu Pierre Louis, Brochu Christian, Chabot Catherine, Jolicoeur Eric, Kawai Stephen, Poupart Marc André, Tsantrizos Youla S, BERNIER Louise G, August 5, 2004: WO/2004/065367 (60 worldwide citation)

An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula (I): wherein wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.